ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.
Company Details
- Employees
- 298
- Founded
- -
- Address
- South San Francisco , Ca 94080, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://arsenalbio.com
- Keywords
- Biotechnology, technology, artificial intelligence, cancer, immunology, cell therapy, machine learning.
- HQ
- South San Francisco , CA
Arsenal Biosciences, Inc. Questions
Arsenal Biosciences, Inc.'s website is https://arsenalbio.com
Arsenal Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/arsenalbio
Arsenal Biosciences, Inc. has
298 employees.
View email and phone details for 298
employees at Arsenal Biosciences, Inc..
Arsenal Biosciences, Inc.'s industry is
Biotechnology Research
Arsenal Biosciences, Inc.'s top competitors are
Allogene Therapeutics,
Kyverna Therapeutics,
Sana Biotechnology, Inc.,
Denali Therapeutics,
Vaxcyte,
Caribou Biosciences,
Mammoth Biosciences,
Arcus Biosciences,
Xaira Therapeutics,
Cargo Therapeutics.
Arsenal Biosciences, Inc.'s categories are Biotechnology Research
Arsenal Biosciences, Inc.'s founding year is 2019
